“Accreditations in Biobanking: A Step Towards Quality and Global Trust”

"Accreditamenti nel Biobanking: Un Passo Verso la Qualità e la Fiducia Globale"

The mutual recognition of accredited biobanks among accreditation bodies represents a crucial milestone in consolidating global trust in the competence of these facilities. Recently, an important national body awarded the second accreditation in the national territory to a research biobank located in Italy. This accreditation follows shortly after the first, obtained by a similar organization in 2022.

During the General Assembly of a significant European accreditation platform, the EN ISO 20387 standard was officially recognized as a harmonized standard for the accreditation of biobanks. Known in Italy as UNI CEI EN ISO 20387:2024, this standard establishes the necessary requirements for competence and impartiality for biobanks, which are dedicated facilities for the collection, preservation, and management of biological material and related clinical data, specifically for research and innovation purposes.

According to estimates from international experts, the biobanking sector is expected to grow significantly in the coming years, with an estimated impact of 2.7% of the global GDP by 2030. In this context, European accreditation bodies have begun issuing the first accreditations, and the recent accreditation activity in Italy suggests a favorable approach to growth and quality in scientific research.

The recognition of the ISO 20387 standard not only lends authority to biobanking processes in Europe but also provides a boost for strengthening international trust. This trust is crucial, as biobanking is inherently characterized by a strongly international nature. Thanks to the accreditation initiative, international mutual recognition agreements are expected to promote the equivalence of various accreditations issued, facilitating the circulation of certified goods and services in global markets.

A key aspect of this evolution consists of peer evaluation checks, which are a guarantee of the reliability and consistency of accreditation processes among bodies. These checks are essential for maintaining high standards of quality, safety, and uniformity in such a delicate and innovative sector.

Recently, a research biobank obtained its accreditation, becoming the second in the country to receive such recognition. This event highlights the importance of a network of accredited biobanks, as it contributes to creating a favorable environment for research and development in the field of biotechnology.

Accreditations like these promote a growth environment by supporting the improvement of scientific practices and encouraging the development of innovative technologies. It is essential that each step of the biobanking process, from collection to preservation and transportation, be managed in a traceable manner and in accordance with the required standards.

Moreover, implementing standard procedures and monitoring associated clinical data allows biobanks to ensure comparability and reproducibility in research results. Working in accordance with the provisions of the ISO 20387 standard enables biobanks to demonstrate their operational competence and the adequacy of their structure.

The requirements established by the standard encompass not just the acquisition, preservation, and distribution of biological material, but also administrative processes such as quality management systems. Adherence to these criteria becomes an indispensable guarantee for both academic and industrial research, confirming a positive impact in the area of personalized medicine and the development of new drugs.

Another consideration is the reliability of research results, which can translate into reduced public healthcare spending. Investing in biobanking and related accredited practices is therefore a strategic move, not only for the scientific community but also for society as a whole.

In conclusion, the landscape of biobanking is rich in opportunities and challenges, with the increasing recognition of harmonized standards and accreditation processes that can contribute to better management of biological material and more reliable research outcomes. To remain competitive and effective in this evolving field, it is crucial to continue fostering such initiatives.

Share Button